RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Kinnevik AB (publ) 10,405,668$79,603,360100.00%
Data Collective IV GP, LLC 5,941,120$45,449,56843.00%
MIC Capital Management UK LLP 8,451,758$64,655,95214.74%
MV Management XI, L.L.C. 788,762$6,034,02910.04%
ArchPoint Investors 1,047,386$8,012,5033.06%
Connective Portfolio Management, LLC 33,000$252,0000.77%
PLATINUM INVESTMENT MANAGEMENT LTD 2,335,132$17,863,7600.70%
Diametric Capital, LP 136,331$1,042,9320.44%
ARK Investment Management 6,876,598$52,605,9730.40%
ALLEN OPERATIONS LLC 217,657$1,665,0760.37%
MARATHON CAPITAL MANAGEMENT 170,615$1,305,2050.33%
Nikko Asset Management Americas, Inc. 3,523,124$26,951,8990.32%
Lingotto Investment Management LLP 775,077$5,929,3390.32%
Values First Advisors, Inc. 53,065$405,9450.26%
Comprehensive Financial Management LLC 941,895$7,205,4970.26%
Duquesne Family Office 906,767$6,9370.25%
Green Alpha Advisors, LLC 34,542$264,2460.20%
Cercano Management LLC 685,018$5,240,3880.19%
Baillie Gifford 24,551,409$187,818,2790.17%
Bienville Capital Management, LLC 58,053$444,1050.12%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.